Authors:
Ben-Ari, Z
Mor, E
Shapira, Z
Tur-Kaspa, R
Citation: Z. Ben-ari et al., Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation, LIVER TRANS, 7(2), 2001, pp. 113-117
Authors:
Ben-Ari, Z
Tur-Kaspa, R
Schafer, Z
Baruch, Y
Sulkes, J
Atzmon, O
Greenberg, A
Levi, N
Fainaru, M
Citation: Z. Ben-ari et al., Basal and post-methionine serum homocysteine and lipoprotein abnormalitiesin patients with chronic liver disease, J INVES MED, 49(4), 2001, pp. 325-329
Authors:
Ben-Ari, Z
Mor, E
Manhaim, V
Barak, O
Bar-Nathan, N
Shaharabani, E
Shapira, Z
Tur-Kaspa, R
Citation: Z. Ben-ari et al., Passive immunization with OMRI-Hep-B for prevention of hepatitis B virus reinfection after liver transplantation, TRANSPLAN P, 33(6), 2001, pp. 2895-2896
Authors:
Erez, E
Ben-Ari, Z
Sharoni, E
Aravot, D
Sahar, G
Tur-Kaspa, R
Vidne, BA
Erman, A
Citation: E. Erez et al., Beta-2 microglobulin and serum creatinine for differentiating between immunoactivation and renal failure after liver transplantation, TRANSPLAN P, 33(6), 2001, pp. 2920-2923
Authors:
Mor, E
Shaharabani, E
Ben-Ari, Z
Bar-Nathan, N
Yussim, A
Shapira, R
Tur-Kaspa, R
Shapira, Z
Citation: E. Mor et al., Experience with 100 liver transplant recipients at the Rabin Medical Center and Schneider Children's Medical Center, TRANSPLAN P, 33(6), 2001, pp. 2943-2944
Authors:
Shapira, R
Mor, E
Bar-Nathan, N
Sokal, EM
Tur-Kaspa, R
Dinari, G
Ben-Ari, Z
Citation: R. Shapira et al., Efficacy of lamivudine for the treatment of hepatitis B virus infection after liver transplantation in children, TRANSPLANT, 72(2), 2001, pp. 333-336
Authors:
Tambur, AR
Ortegel, JW
Ben-Ari, Z
Shabtai, E
Klein, T
Michowiz, R
Tur-Kaspa, R
Mor, E
Citation: Ar. Tambur et al., Role of cytokine gene polymorphism in hepatitis C recurrence and allograftrejection among liver transplant recipients, TRANSPLANT, 71(10), 2001, pp. 1475-1480
Citation: Z. Ben-ari et al., The addition of mycophenolate mofetil for suppressing hepatitis B virus replication in liver recipients who developed lamivudine resistance - No beneficial effect, TRANSPLANT, 71(1), 2001, pp. 154-156
Authors:
Zemel, R
Kazatsker, A
Greif, F
Ben-Ari, Z
Grief, H
Almog, O
Tur-Kaspa, R
Citation: R. Zemel et al., Mutations at vicinity of catalytic sites of hepatitis C virus NS3 serine protease gene isolated from hepatocellular carcinoma tissue, DIG DIS SCI, 45(11), 2000, pp. 2199-2202
Authors:
Ben-Ari, Z
Mor, E
Shaharabani, E
Bar-Nathan, N
Shapira, Z
Tur-Kaspa, R
Citation: Z. Ben-ari et al., Conversion of liver allograft recipients from cyclosporine A to FK 506 immunosuppressive therapy, TRANSPLAN P, 32(4), 2000, pp. 709-710
Authors:
Ben-Ari, Z
Mor, E
Shaharabani, E
Bar-Nathan, N
Shapira, Z
Tur-Kaspa, R
Citation: Z. Ben-ari et al., Combination of interferon-alpha and ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation, TRANSPLAN P, 32(4), 2000, pp. 714-716
Authors:
Kitay-Cohen, Y
Ben-Ari, Z
Tur-Kaspa, R
Fainguelernt, H
Lishner, M
Citation: Y. Kitay-cohen et al., Extension of transplantation free time by lamivudine in patients with hepatitis B-induced decompensated cirrhosis, TRANSPLANT, 69(11), 2000, pp. 2382-2383
Authors:
Kitay-Cohen, Y
Amiel, A
Hilzenrat, N
Buskila, D
Ashur, Y
Fejgin, M
Gaber, E
Safadi, R
Tur-Kaspa, R
Lishner, M
Citation: Y. Kitay-cohen et al., Bcl-2 rearrangement in patients with chronic hepatitis C associated with essential mixed cryoglobulinemia type II, BLOOD, 96(8), 2000, pp. 2910-2912
Authors:
Ben-Ari, Z
Broida, E
Monselise, Y
Kazatsker, A
Baruch, J
Pappo, G
Skappa, E
Tur-Kaspa, R
Citation: Z. Ben-ari et al., Syncytial giant-cell hepatitis due to autoimmune hepatitis type II (LKM1+)presenting as subfulminant hepatitis, AM J GASTRO, 95(3), 2000, pp. 799-801
Authors:
Ben-Ari, Z
Broida, E
Kittai, Y
Chagnac, A
Tur-Kaspa, R
Citation: Z. Ben-ari et al., An open-label study of lamivudine for chronic hepatitis B in six patients with chronic renal failure before and after kidney transplantation, AM J GASTRO, 95(12), 2000, pp. 3579-3583